MC
ITCI

Meteora Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Meteora Capital’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,200
Closed -$5.04M – 248
2025
Q1 		$5.04M Buy
+38,200
New +$4.76M 1.62% 21

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Meteora Capital's ITCI Position: Q2 2025 in Review

Meteora Capital sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 38,200 shares — an estimated $5.04M sold.

Meteora Capital first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $5.04M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Meteora Capital reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Meteora Capital sold 38,200 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $5.04M.
  • Meteora Capital first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
  • Meteora Capital's Intra-Cellular Therapies Inc. position peaked at $5.04M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Meteora Capital's 13F filing for Q2 2025, filed 14 Aug 2025.